“…The structures of benzo [ d ] [1,3] azoles, such as benzimidazole (BZM), benzothiazole (BTA), and benzoxazole (BOX), are highly valued heterocyclic scaffolds in the design and synthesis of new drugs and bioactive agents. These heterocyclic nuclei are privileged pharmacophores that exhibit an inherent affinity for various types of receptors involved in different biological signaling pathways, whose derivatives have shown multiple pharmacological functions, including anti-inflammatory, diuretic, antiviral, anti-insomnia, antiparasitic, anticancer, among others ( Scheme 1 ) [ 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 ].…”